China gene editing startup YolTech raises $70M to move CRISPR therapies forward

YolTech Therapeutics CEO Yuxuan Wu (L) and chief technology officer Zi Jun Emma Wang May 28, 2026 08:30 AM EDTUpdated May 28, 08:41 PM FinancingR&DCell/Gene Tx Ex­clu­sive: Chi­na gene edit­ing start­up YolTech rais­es $70M to move CRISPR ther­a­pies for­ward Ryan Cross Senior Science Correspondent One of Chi­na’s most pro­lif­ic gene edit­ing com­pa­nies has raised its biggest round of fund­ing yet, ahead of plans to go pub­lic in Hong Kong. … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER